Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Publications

Search Items: PLEURAL NEOPLASMS - PATHOLOGY , . hits: 10

2016

Geltner, C; Errhalt, P; Baumgartner, B; Ambrosch, G; Machan, B; Eckmayr, J; Klikovits, T; Hoda, MA; Popper, H; Klepetko, W; Austrian Mesothelioma Interest Group (AMIG) Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG).
Wien Klin Wochenschr. 2016; 128(17-18):611-617 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Hoda, MA; Dong, Y; Rozsas, A; Klikovits, T; Laszlo, V; Ghanim, B; Stockhammer, P; Ozsvar, J; Jakopovic, M; Samarzija, M; Brcic, L; Bendek, M; Szirtes, I; Reid, G; Kirschner, MB; Kao, SC; Opitz, I; Weder, W; Frauenfelder, T; Nguyen-Kim, TD; Aigner, C; Klepetko, W; van Zandwijk, N; Berger, W; Dome, B; Grusch, M; Hegedus, B Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study.
Eur J Cancer. 2016; 63(1):64-73 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Ghanim, B; Klikovits, T; Hoda, MA; Lang, G; Szirtes, I; Setinek, U; Rozsas, A; Renyi-Vamos, F; Laszlo, V; Grusch, M; Filipits, M; Scheed, A; Jakopovic, M; Samarzija, M; Brcic, L; Stancic-Rokotov, D; Kern, I; Rozman, A; Dekan, G; Klepetko, W; Berger, W; Glasz, T; Dome, B; Hegedus, B Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.
Br J Cancer. 2015; 112(5): 783-792. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Laszlo, V; Hoda, MA; Garay, T; Pirker, C; Ghanim, B; Klikovits, T; Dong, YW; Rozsas, A; Kenessey, I; Szirtes, I; Grusch, M; Jakopovic, M; Samarzija, M; Brcic, L; Kern, I; Rozman, A; Popper, H; Zöchbauer-Müller, S; Heller, G; Altenberger, C; Ziegler, B; Klepetko, W; Berger, W; Dome, B; Hegedus, B Epigenetic down-regulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
J Pathol. 2015; 237(2):203-214
Web of Science PubMed FullText FullText_MUG

 

2014

Arzt, L; Quehenberger, F; Halbwedl, I; Mairinger, T; Popper, HH BAP1 protein is a progression factor in malignant pleural mesothelioma.
Pathol Oncol Res. 2014; 20(1):145-151
Web of Science PubMed FullText FullText_MUG

 

Brčić, L; Jakopović, M; Brčić, I; Klarić, V; Milošević, M; Sepac, A; Samaržija, M; Seiwerth, S Reproducibility of histological subtyping of malignant pleural mesothelioma.
Virchows Arch. 2014; 465(6): 679-685. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2013

Lindenmann, J; Matzi, V; Neuboeck, N; Anegg, U; Maier, A; Smolle, J; Smolle-Juettner, FM Multimodal therapy of malignant pleural mesothelioma: is the replacement of radical surgery imminent?
Interact Cardiovasc Thorac Surg. 2013; 16(3):237-243 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Stanzel, S; Beham-Schmid, C; Aigner, R Ein seltener Fall eines undifferenzierten Thymuskarzinoms mit multipler Metastasierung.
Rofo. 2013; 185(4):367-369 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2012

Hoda, MA; Münzker, J; Ghanim, B; Schelch, K; Klikovits, T; Laszlo, V; Sahin, E; Bedeir, A; Lackner, A; Dome, B; Setinek, U; Filipits, M; Eisenbauer, M; Kenessey, I; Török, S; Garay, T; Hegedus, B; Catania, A; Taghavi, S; Klepetko, W; Berger, W; Grusch, M Suppression of activin A signals inhibits growth of malignant pleural mesothelioma cells.
Br J Cancer. 2012; 107(12):1978-1986 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Wiesner, T; Fried, I; Ulz, P; Stacher, E; Popper, H; Murali, R; Kutzner, H; Lax, S; Smolle-Jüttner, F; Geigl, JB; Speicher, MR Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations.
J Clin Oncol. 2012; 30(32):e337-e340 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

© Med Uni GrazImprint